| Literature DB >> 35456778 |
Simone Eckstein1, Rosina Ehmann1, Abderraouf Gritli2, Mohamed Ben Rhaiem2, Houcine Ben Yahia2, Manuel Diehl1, Roman Wölfel1, Susann Handrick1, Mohamed Ben Moussa3, Kilian Stoecker1.
Abstract
The rapid spread of SARS-CoV-2 clearly demonstrated the potential of zoonotic diseases to cause severe harm to public health. Having limited access to medical care combined with severe underreporting and a lack of active surveillance, Africa carries a high burden of neglected zoonotic diseases. Therefore, the epidemiological monitoring of pathogen circulation is essential. Recently, we found extensive Middle East respiratory syndrome coronavirus (MERS-CoV) prevalence in free-roaming dromedary camels from southern Tunisia. In this study, we aimed to investigate the seroprevalence, and thus the risk posed to public health, of two additional viral and two bacterial pathogens in Tunisian dromedaries: Rift Valley fever virus (RVFV), foot-and-mouth disease virus (FMDV), Coxiella burnetii and Brucella spp. via ELISA. With 73.6% seropositivity, most animals had previously been exposed to the causative agent of Q fever, C. burnetii. Additionally, 7.4% and 1.0% of the dromedaries had antibodies against Brucella and RVFV, respectively, while no evidence was found for the occurrence of FMDV. Our studies revealed considerable immunological evidence of various pathogens within Tunisian dromedary camels. Since these animals have intense contact with humans, they pose a high risk of transmitting serious zoonotic diseases during active infection. The identification of appropriate countermeasures is therefore highly desirable.Entities:
Keywords: camels; epidemiology; monitoring; seroprevalence; surveillance; zoonotic agents
Year: 2022 PMID: 35456778 PMCID: PMC9028256 DOI: 10.3390/microorganisms10040727
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Schematic overview of pathogen transmission pathways. Rift Valley fever virus (RVFV, green), Foot-and-mouth disease virus (FMDV, purple), Brucella spp. (pink) and Coxiella burnetii (yellow) can be transmitted from dromedary camels both directly and indirectly. Furthermore, RVFV and C. burnetii can be transmitted by mosquitos and tick bites, respectively.
Figure 2Sampling locations and results of serological screening. (A) Map of Tunisia with its different governorates. The four main sampling sites in Kebili (brown): Bazma, Mahrouga, Douz and Ksar Ghilane are highlighted with red dots. (B) Seropositivity of animals for the different pathogens sorted by sampling area. (C) Venn diagram depicting the ELISA results. Yellow = Coxiella burnetii; pink = Brucella spp.; green = RVFV; blue = MERS-CoV; purple = FMDV; light gray = borderline; dark gray = negative. Dotted line: 50%. The numbers for MERS-CoV seroprevalence were adapted from our previous study [31].
Summary for semi-quantitative result interpretation for all ELISA kits used in this study. For all assays, extinction (OD) was measured at 450 nm. S = sample; Cal = calibrator; NC = negative control; PC = positive control.
| ELISA | Result | Formula | ||
|---|---|---|---|---|
| Negative | Borderline | Positive | ||
| Anti-Brucella ELISA camel | Ratio < 0.8 | Ratio ≥ 0.8– < 1.1 | Ratio ≥ 1.1 |
|
| ID Screen®
| S/P% ≤ 40% | S/P% > 40%– ≤ 50% | S/P% > 50% |
|
| ID Screen®
| S/N% > 50% | S/N% < 40%– ≤ 50% | S/N% ≤ 40% |
|
| PrioCHECK® FMDV NS | PI = < 50% | / | PI = ≥ 50% |
|
Seropositive dromedary camels by zoonotic diseases and different sampling parameters. Gray shaded lines: Male animals kept enclosed for transport and patrol purposes.
| Sampling | No. | No. Seropositive Dromedaries (%) | ||
|---|---|---|---|---|
|
| Rift Valley Fever Virus | |||
| 500 | 368 (73.6) | 37 (7.4) | 5 (1.0) | |
|
| ||||
|
| 130 | 68 (52.3) | 5 (3.8) | 5 (3.8) |
|
| 370 | 300 (81.1) | 32 (8.6) | 0 |
|
| ||||
|
| 45 | 13 (28.9) | 0 | 0 |
| 0–6 months | 4 | 0 | 0 | 0 |
| 6–24 months | 41 | 13 (31.7) | 0 | 0 |
|
| 455 | 355 (78.0) | 37 (8.1) | 5 (1.1) |
| 2–6 years | 80 | 40 (50.0) | 4 (5.0) | 0 |
| 6–12 years | 179 | 142 (79.3) | 18 (10.1) | 4 (2.2) |
| 12–25 years | 190 | 167 (87.9) | 14 (7.4) | 1 (0.5) |
| >25 years | 6 | 6 (100) | 1 (16.7) | 0 |
|
| ||||
| 211 | 144 (68.2) | 5 (2.4) | 0 | |
| Site 1 | 28 | 9 (32.1) | 0 | 0 |
| Site 2 | 20 | 7 (35.0) | 2 (10.0) | 0 |
| Site 3 | 30 | 22 (73.3) | 0 | 0 |
| Site 4 | 20 | 19 (95.0) | 0 | 0 |
| Site 5 | 73 | 54 (74.0) | 3 (4.1) | 0 |
| Site 6 | 40 | 33 (82.5) | 0 | 0 |
| 167 | 143 (85.6) | 20 (12.0) | 2 (1.2) | |
| Site 1 | 25 | 21 (84.0) | 0 | 0 |
| Site 2 | 30 | 28 (93.3) | 2 (6.7) | 0 |
| Site 3 | 15 | 14 (93.3) | 5 (33.3) | 0 |
| Site 4 | 15 | 15 (100) | 3 (20.0) | 0 |
| Site 5 | 21 | 18 (85.7) | 2 (9.5) | 0 |
| Site 6 | 16 | 14 (87.5) | 4 (25.0) | 0 |
| Site 7 | 45 | 33 (73.3) | 4 (8.9) | 2 (4.4) |
| 53 | 22 (41.5) | 3 (5.7) | 3 (5.7) | |
| Site 1a | 4 | 3 (75.0) | 0 | 1 (25.0) |
| Site 1b | 4 | 1 (25.0) | 0 | 0 |
| Site 2 | 24 | 10 (41.7) | 2 (8.3) | 1 (4.2) |
| Site 3 | 18 | 7 (38.9) | 1 (5.6) | 1 (5.6) |
| Site 4 | 3 | 1 (33.3) | 0 | 0 |
| 69 | 58 (84.1) | 9 (13.0) | 0 | |
| Site 1 | 42 | 35 (83.3) | 5 (11.9) | 0 |
| Site 2 | 27 | 23 (85.2) | 4 (14.8) | 0 |
|
| ||||
|
| 382 | 306 (80.1) | 28 (7.3) | 0 |
|
| 118 | 62 (52.5) | 9 (7.6) | 5 (4.2) |
Bold and italicized headings describe the superior category of the tested variables. Bold subheading describe the respective subordinate categories.
Univariate and multivariate analysis of anti-C. burnetii IgG seropositivity. Borderline results were considered negative for statistical analyses.
| Variable | Univariate | Multivariate c | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
|
| ||||
| Female | 3.91 (2.5–5.94) | <0.0001 (****) a | 0.7846 (0.21–2.50) | 0.6962 (ns) |
|
| ||||
| Adult (>2 y) | 8.74 (4.50–17.71) | <0.0001 (****) a | 16.06 (7.49–36.92) | <0.0001 (****) |
|
| ||||
| Free roaming | 3.64 (2.356–5.60) | <0.0001 (****) a | 14.4 (3.85–61.77) | 0.0001 (***) |
|
| <0.0001 (****) b | |||
| Ksar Ghilane | 0.35 (0.20–0.61) | 0.0002 (***) | ||
| Bazma | 3.62 (2.10–6.46) | <0.0001 (****) | ||
| Douz | 0.54 (0.25–1.14) | 0.1067 (ns) | ||
| Mahrouga | 0.93 (0.44–2.10) | 0.8481 (ns) |
a Fisher’s exact test; b Chi-square test; c multiple logistic regression. Bold and italicized headings describe the superior category of the tested variables. **** p < 0.0001; *** p ≤ 0.001; ns not significant (p > 0.05)